Achieve Life Sciences Inc. is implementing a 1-for-10 reverse stock split of its issued and outstanding common stock, effective May 23.
The company's shares will trade on a split-adjusted basis beginning May 24.
Achieve Life Sciences implements 1-for-10 reverse stock split
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Achieve Life Sciences Inc. is implementing a 1-for-10 reverse stock split of its issued and outstanding common stock, effective May 23.
The company's shares will trade on a split-adjusted basis beginning May 24.